Information gap may skew mastectomy decisions

Share this article:

Women with early-stage breast cancer often lacked knowledge about their disease and were not asked their preference regarding surgery, according to recent survey findings.

In order to evaluate the quality of decisions about surgery for early-stage breast cancer, a team led by Clara N. Lee, MD, MPP, the director of surgical research at the University of North Carolina School of Medicine in Chapel Hill, mailed surveys to survivors of stage I/II breast cancer who had been treated at one of four academic medical centers in Chapel Hill; Boston, Massachusetts; and San Francisco, California. The surveys measured patient knowledge, concordance between goals and treatments, and involvement in decisions.

The 440 respondents answered about half the survey questions correctly (mean overall knowledge score was 52.7%). Less than half the women (45.9%) knew that local recurrence risk is higher after breast conservation compared with mastectomy, and just slightly more than half (55.7%) knew that survival is equivalent for the two options.

Although most of the participants (89.0%) stated that they had treatment concordant with their goals, only 48.6% reported that their surgeon asked them about their preference regarding surgical treatment. Women preferring mastectomy were less likely to have treatment concordant with their goals (80.5%) than did women preferring partial mastectomy (92.6%). The respondents reported more frequent discussions of partial mastectomy and its advantages than of mastectomy.

These findings indicate that improvements in the quality of decisions about breast cancer surgery are needed, wrote Lee and colleagues in Journal of the American College of Surgeons (2012;214[1]:1-10), noting that this will require interventions to enhance patient knowledge and incorporate preferences into the decision-making process.

Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

What is this?

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Web Exclusives

Fewer cardiac scans in low-risk childhood cancer survivors can safely reduce costs ...

A less frequent screening schedule would both reduce health care charges and still protect low-risk childhood cancer survivors from heart ailments caused by drug therapy, according to recently published findings.

Everolimus does not improve overall survival of advanced liver cancer

Despite strong preclinical data, the drug everolimus failed to improve overall survival in patients with advanced liver cancer, compared to placebo, according to a study.

Presence of uterine cancers examined among women at the time of hysterectomy ...

Among women undergoing a minimally invasive hysterectomy using electric power morcellation, uterine cancers were present in 27 per 10,000 women at the time of the procedure, according to a new study.